Lupin Establishes Wholly Owned Thailand Subsidiary

Lupin incorporated a 100% owned subsidiary, Lupin (Thailand) Limited, on April 17, 2026.
The subsidiary will import, market, distribute, and sell pharmaceutical products in Thailand.
Initial paid-up capital is 3 million Baht, funded entirely through cash consideration.
Disclosure made pursuant to SEBI Listing Regulations, requiring no governmental approvals.